This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!
Celldex Therapeutics Inc
CLDX : NASDAQ : Health Care
$18.30 1.50 | 8.70%
Today's Range: 16.60 - 18.14
Avg. Daily Volume: 2,925,100
12/18/14 - 9:38 AM ET

PEER GROUP: Biotechnology



Ticker Company Name Recent
Price($)
Market
Cap($M)
Price/
Earnings
Net Sales
TTM($M)
Net Income
TTM($M)
CLDX CELLDEX THERAPEUTICS INC 18.19 1629.62 n/m 2.73 -61.77
MYGN MYRIAD GENETICS INC 35.13 2563.96 19.74 744.59 9.14
BLUE BLUEBIRD BIO INC 86.12 2482.24 n/m 25.37 99.46
DYAX DYAX CORP 14.23 1941.16 n/m 72.55 36.64
PTCT PTC THERAPEUTICS INC 55.33 1859.25 n/m 17.00 -26.56
IRWD IRONWOOD PHARMACEUTICALS INC 14.91 1844.19 n/m 43.39 -3.21
ACOR ACORDA THERAPEUTICS INC 38.64 1620.87 69.00 376.20 15.64
CBPO CHINA BIOLOGIC PRODUCTS INC 65.08 1604.68 25.42 227.86 16.99
OPHT OPHTHOTECH CORP 47.64 1603.13 n/m 39.58 n/a
ANAC ANACOR PHARMACEUTICALS INC 34.68 1487.67 29.39 19.53 62.32
NVAX NOVAVAX INC 5.93 1414.17 n/m 32.68 95.32
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

CLDX Ind Avg S&P 500
n/m 66.62 19.74
 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades


Top Rated Stocks Top Rated Funds Top Rated ETFs